EAACI 2020

06/06/2020 - 08/06/2020

Digital

Watch the content from our past Annual Congresses – re-discover talks that impressed you, or refresh your knowledge with lectures you did not have the chance to listen to before.

Filter

What are you looking for?

Category
- adolescent
- aerobiology and pollution
- allergen immunotherapy (AIT)
- AllergoOncology
- allergy asthma and a sport
- allergy diagnosis
- allied health and primary care
- anaphylaxis
- angioedema
- artificial intelligence (AI)
- asthma
- basic immunology
- biologicals
- comparative veterinary allergology
- consensus document
- COVID-19
- dermatology
- drug allergy
- EAACI position paper
- EAACI Task Force report
- ENT
- environmental allergy and climate change
- eosinophilic esophagitis (EoE)
- epidemiology
- epithelial cell biology
- exposome
- food allergy
- food allergy and anaphylaxis
- genomics and proteomics
- hypersensitivity
- immune deficiencies and autoimmunity
- immunomodulation and nutrition
- infections
- insect venom hypersensitivities
- mastocytosis and mast cells
- microbiome
- nasal polyposis
- occupational allergy
- ocular allergy
- OMIC technologies in allergy research
- One Health
- pediatrics
- prevention
- systems medicine
- T2 diseases
- transitional
Type
- Abstract Book
- Poster
- Presentation
Year
- 2013
- 2014
- 2015
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
Keywords
- nasal polyps…)
- sinusitis
- vaccines and mechanisms
- “omics” and systems biology
- “omics” and systems biology
- (reverse) zoonosis
- AAMP
- Abbott Laboratories
- Abdominal pain
- ABPA
- ACE2
- Acoustic rhinometry
- Adherence
- Adjuvant
- Adjuvants
- adolescent
- Adolescents
- adolesent and young adult (AYA)
- Adrenaline
- Adrenaline auto-injector
- adult
- adults
- adverse drug reaction
- advocacy
- aerd
- aerobiology
- aerosolization
- AGREE II
- Aimmune Therapeutics
- Air pollutant
- Air pollution
- Airborne enzyme
- airways
- AIT
- Algorithm
- ALK
- allegen immunotherapy (AIT)
- allergen
- allergen exposure challenge
- allergen immunotherapy
- allergen immunotherapy (AIT)
- Allergen labelling
- Allergen sequence database
- allergen symphony
- Allergen-free foods
- allergens and epitopes
- Allergens and epitopes
- allergic asthma
- allergic bronchopulmonary aspergillosis
- allergic conjunctivitis
- Allergic conjunctivitis (AC)
- Allergic contact dermatitis
- allergic disease
- allergic diseases
- allergic rhinitis
- Allergic rhinitis (AR)
- allergicdiseases
- allergicrhinitis
- allergies to cats
- allergoid-mannan conjugates
- AllergoOncology WG
- Allergopharma
- allergy
- allergy diagnosis
- Allergy diagnosis
- allergy epidemiology
- allergy hypersensititvy
- allergy immunotherapy
- allergy management
- Allergy risk
- allergy test
- allergy therapeutics
- allergy treament
- allergy treatment
- Allergy treatment
- allergy/hypersensitivity
- alpha-gal allergy
- ALR
- Alternaria
- altitude
- Anaphylaxis
- Angioedema
- angiotensin-convertingenzyme2
- angiotensin-convertingenzymeII
- Animal models
- Anosmi
- anti-epileptic drugs
- antibiotics
- Antibodies
- antibody
- antibody-dependentenhancement
- antibodydynamics
- antigen presenting cells
- Antolimab
- Api m 10
- APOE
- ARPC1B
- Artificial intelligence
- Asthma
- asthma care
- asthma control
- asthma exacerbations
- asthma inflammatory
- asthma management
- asthma risk
- Asthma treatment
- Asthma treatment
- asthmatic patients
- Astrazeneca
- asymptomatic
- atopic dermatitis
- Atopic dermatitis
- Atopic dermatitis (AD)
- Atopic deseases
- Atopic eczema
- Atopic eosinophilic asthma
- atopy
- Autoallergen
- Autoimmunity
- Autoinflammation
- Avapritinib
- Azelastine fluticasone
- B cells
- B regulatory cells
- bacterial lysate
- bacterial lysates
- bacterial mucosal immunotherapy
- bacterial products
- Barrier
- Basic and Clinical Immunology Section
- Basic immunology
- basic mechanisms
- Basic mechanisms
- Basophil
- Basophil activation test
- basophil activation test (BAT)
- Bathing
- Bcells
- Beijing
- Benralizumab
- berotralstat
- Bet v 1
- beta-lactam
- beta-lactoglobulin
- Big data
- bigdata
- BioCryst
- Bioinformatics
- Biological detergents
- biologicals
- Biologics
- biomarker
- Biomarkers
- biosafety
- Biotin
- Birch
- Birch pollen
- blood
- blood eosinophil
- BluePrint Medicines
- BNT162b2
- Bovine milk
- Breast milk
- Breastfeeding
- Breg cells
- bronchial allergen challenge
- bronchial asthma
- bronchial thermoplasty
- bronchiectasis
- Bronchiolitis
- Bronchoconstriction
- BTK
- c-kit
- C1 inhibitor
- C1-INH
- cabbage
- cancer
- cannabis allergy
- case study
- cats
- causality
- Cellular test
- challenge tests
- Challenge tests
- chemotherapy
- Childhood allergies
- childhood asthma
- childhoodvaccination
- children
- china
- chlorhexidine
- chlorination by-products
- Chronic respiratory
- Chronic rhinosinusitis
- Chronic rhinosinusitis with nasal polyposis (CRSwNP)
- chronic rhinosinusitis with nasal polyps (CRSwNP)
- chronic spontaneous urticaria
- Chronic spontaneous urticaria (CSU)
- chronic urticaria
- chronicrhinosinusitis
- chronicrhinosinusitiswithnasalpolyps
- chronicurticaria
- chronis rhinosinusitis
- classification
- climate
- climate change
- Clinical aspects
- clinical cases
- clinical endotypes
- Clinical immunology
- Clinical immunology Food allergy
- Clinical practice
- clinical tolerance
- clinicalimmunology
- Cluster analysis
- CMA
- Collegen-binding receptor
- common cold
- companion animals and pets
- Company Sponsored Symposia
- complex world of allergy
- compliance
- component resolved diagnosis
- Component resolved diagnosis (CRD)
- component-resolved diagnosis (CRD)
- Conjunctiva
- conjunctivitis
- Consensus
- consensus document
- contact allergen
- contact dermatitis
- Contact urticaria
- containment
- contraindications
- coronavirus
- coronavirusdisease2019
- Cost-effectiveness
- cough
- COVID
- COVID-19
- COVID-19 lockdown
- COVID-19 pandemic
- COVID-19 vaccine
- COVID-19[SupplementaryConcept]
- COVID-19diagnostictesting[SupplementaryConcept]
- COVID-19vaccines
- COVID‐19
- COVID19
- Cow's milk
- Cow's milk allergy
- CRISPR
- criticalillness
- Cross-reactivity
- CRSwNP
- CSL Behring
- Cutaneous manifestation
- cyclosporine
- cytokine
- DAMP
- danger signals
- Danger signs
- Danone/Nutricia
- dbv technologies
- dbv712
- Deep learning
- delabelling
- DELPHI
- Dendritic cells
- dermatologic diseases
- Dermatology
- desensitization
- dexamethasone
- DGAKI
- diagnosis
- diet
- dietary management
- Differential diagnosis
- digital anamorphosis
- disease (CRD)
- disease burden
- disease control
- disease model
- disease transmission
- disinfection by-products
- disruptive IgE antibody
- DNase
- drug allergy
- Drug allergy
- Drug desensitisation
- Drug hypersensitivity
- drug provocation test
- drug provocation test (dpt)
- Drug provocation tests
- dupilumab
- Dysbiosis
- E-cigarette
- eaaci hybrid congress 2021
- eaaci hybrid congress 2022
- eaaci2021
- early diet
- ECDA
- ecosystem
- eczema
- Education
- EETosis
- efficacy
- Egg allergy
- EGR-1
- eHealth
- Eldery
- Elimination diet
- Emollient
- Endotype
- Endotypes
- ENT
- ENT (rhinitis
- environment
- Environment and hygiene hypothesis
- Environment and Immunology StandUp Talks
- Environmental exposure chamber (EEC)
- environmentalhealth
- Enzyme-LinkedImmunosorbentAssay[Mesh]
- eosinophil
- eosinophilic diseases
- eosinophilic fasciitis
- Eosinophilic granulomatosis with polyangiitis (EGPA)
- Eosinophils
- Epicutaneous
- Epicutaneous immunotherapy
- Epidemiology
- epigenetic
- Epithelial barrier
- Epithelial barrier hypothesis
- epithelialcell
- Epithelium
- Epitome
- Epitope specific IgA
- Esophagitis
- EU
- European parliament
- evidence-based
- exacerbations
- exercise
- Exercise induced anaphylaxis (EIAn)
- Exercise induced asthma
- exposome
- faam-eurobat digital 2020
- Faes Farma
- fermentedvegetable
- fiber
- Flow cytometric
- Flow cytometry
- flow-diagram
- flowcytometry
- food additives
- food allergy
- Food allergy
- Food aversion
- food labelling
- Food processing
- food protein induced enterocolitis syndrome (FPIES)
- Food-dependent exercise-induced anaphilaxis (FDEIAn)
- Food-induced anaphylaxis (FIA)
- Fungi
- fungus
- Gene expression
- Genetics
- Genome-wide association study (GWAS)
- Global air quality
- global atlas
- glycans
- GRADE
- Grant application
- GSK
- guidelines
- gut microbiome
- Gut microbiota
- HAE
- HAL Allergy
- healthier environment
- Helicobacter pylori
- Helminth infection
- hereditary angioedema
- Hereditary angioedema (HAE)
- Histamine
- Histamine intolerance
- hives
- HMO
- Hologenome
- House dust mite
- House dust mite (HDM)
- house dust mites
- Human bronchial smooth muscle cells (BMSC)
- hygiene
- Hypereosinophilic syndrome (HES)
- hyperinflammation
- hypersensitivity
- hypersensitivity reactions
- ICD-11
- IgE
- IL-37b
- imaging
- Immune amnesia
- Immune deficiencies
- Immune health
- immune phenotype
- immune response
- immune system
- Immune tolerance
- immunecomplex
- immuneresponse
- Immunization
- immunodeficiencies
- immunoglobulinM
- immunoglobulins
- Immunologic tests
- Immunologic tests
- immunology
- Immunomodulators
- immunotherapy
- Immunotherapy and tolerance induction
- Immunotherapy clinical
- Immunotherapy vaccines and mechanisms
- Immunotherapy vaccines and mechanisms
- implementationscience
- In vitro assays
- Inborn errors of immunity (IEI)
- Infections
- inferiorturbinate
- Inflammasome
- Inflammation
- Inflammatory bowel disease (IBD)
- inflammatoryendotype
- innate immune training
- Innate immunity
- innate immunity
- Innate lymphoid cells and NK cells
- innateimmunity
- Innovation
- Insect Venom Allergy
- insects
- integrated care
- Integrines
- interferon
- Interferons
- Interleukins
- international classification of diseases (ICD)
- international consensus
- intradermal test
- Iodinated contrast media
- italy
- itch
- Kawasakisyndrome
- kimchi
- Lactobacillus
- lanadelumab
- learning methods
- LETI Pharma
- ligelizumab
- Lipid transfer protein (LTP)
- Local allergic rhinitis
- Lolium Perenne
- long-term immunity
- Long-term prophylaxis
- LTRA
- Lung diseases other than asthma and COPD
- lung function
- lung function test
- Lung function tests
- lymphocyte transformation test (LTT)
- Lymphocytes
- Machine learning
- Macrophages
- Malignant
- management
- marketing authorization
- Masitinib
- mast cell
- Mast cells
- Mast cells
- Mast cells Dermatology
- mastocytosis
- Mastocytosis scale (QLMS)
- mechanisms
- Medthority CME supported by Novartis
- memory B cells
- Menarini Group
- mental health
- Mepolizumab
- Metabolite
- metabolites
- Metabolomics
- Metalloproteinase 9
- mHealth
- Microbial Disease
- microbial products
- Microbiome
- microbiota
- MicroCrystalline
- micronutrient
- MicroRNA (miRNA)
- Mobile health (mHealth)
- Moisturisers
- Molecular phenotypes
- molecularinteractionassay
- Molecules
- monoclonal Abs
- monocytes
- MOOC
- MRGPRX2
- mRNA
- mRNA vaccines
- Multiple myeloma
- multisystem allergy
- multisysteminflammatorysyndrome
- mumps‐measles‐rubella
- myeloperoxidase
- nasal allergen challenge
- nasal endoscopy
- nasal polyposis
- nasal polyps…)
- neonates
- Nestlé Health Science
- Nestlé Nutrition Institute
- Neuroimmunology
- Neuronal control
- Neutralizing[Mesh]
- neutralizingantibody
- neutrophil extracellular traps (NETs)
- neutrophilextra-cellulartraps(NETs)
- neutrophils
- New challenges
- newborns
- Next generation
- NLR
- non-specialist care
- non-steroidal anti-inflammatory drugs (NSAID)
- non-steroidal anti-inflammatory drugs exacerbated disease (NERD)
- noninvasive diagnosis
- Noucor
- Novartis
- Novel mechanisms
- NSAID
- nsaid-exacerbated respiratoy disease (NERD)
- Nutrition
- Obesity
- Occupational asthma
- occupational exposure
- Ocular allergy
- older adults
- Olfactory disturbance
- Olink
- OM Pharma
- omalizumab
- omic
- One Health
- OneHealth
- Oral allergy syndrome (OAS)
- oral challenge
- oral food challenge
- Oral immunotherapy
- outbreak
- Outcome measures
- PAAAM 2021
- PAAM 2021
- PAAM Digital 2021
- paediatric awareness
- Paediatrics
- PAF
- PAMP
- Panallergen
- pandemic
- Particular matter (PM)
- Patch test
- Patch tests
- patient care
- patient reported outcome
- peak expiratory flow
- peak expiratory flow (PEF)
- Peanut
- Peanut allergy
- pediatric
- pediatric aspects
- pediatric asthma
- pediatric atopic dermatitis
- pediatrics
- Peptide immunotherapy
- perioperative allergy
- personalized medicine
- Personalized medicine
- pharmacoeconomics
- Pharmacology and pharmacogenomics
- Pharming
- Phase-3 study
- Phenotype
- phenotypes
- physiology
- Pine nut allergy
- PIPEline
- Placebo effect
- Plane tree
- Platanus hybrida
- Pneumology
- pneumonia
- Polish Allergology Society
- Pollen
- Pollen food syndrome
- Pollen forecast
- Pollen monitoring
- pollutants
- pollution
- polyethilen glycol
- polyethylene glycol
- PRACTALL
- prebiotics
- Precision medicine
- precision medicine
- prediction
- Prediction model
- Pregnancy
- Prematurity
- Prevention
- primary care
- primary immunodeficiency
- Probiotic
- probiotics
- proctocolitis
- Prophylactic Treatment
- proresolvinglipids
- protection
- protectiveantibodies
- protein contact dermatitis
- proteomics
- Proteotomics
- Proton pump inhibitor
- pruritus
- Psoriasis
- psychological effects
- psychology
- pulmonary rehabilitation
- Purina Institute
- Quality-of-life
- qualitycriteria
- Questionnaire
- race
- Ragweed
- randomized controlled trial
- Rapid drug desensitization
- Real life
- real-life
- real-world evidence
- Recipe
- recreational exposure
- RED-ZONE
- Regulatory aspects
- regulatory authorities
- Relegating OCS to last resort: Creating a paradigm shift in asthma management
- Remodelling
- reslizumab
- respiratory allergies
- respiratory allergy
- Respiratory infections
- Revenio
- Rhinitis
- Rhinitis Monitoring
- Rhinoconjunctivitis
- Rhinosinusitis (RS)
- Rhinovirus
- risk assessment
- risk factors
- riskfactors
- RLR
- rupatadine
- safety
- SAM 2021
- SAM2021
- SANI
- Sanofi Regeneron
- SARC-CoV-2
- SARS-CoV
- SARS-CoV-2
- SARS-CoV-2 vaccine
- SARS‐CoV‐2
- Satellite Symposia
- SCARs (severe cutaneous adverse drug reactions)
- scientific career
- scoring system
- self‐management
- sensitization
- sensitization profile
- Sepsis
- sequencing (NGS)
- severe allergic reactions
- severe asthma
- Severe cutaneous adverse drug reactions (SCARs)
- severe cutaneous adverse drug reactons
- severe eisinophilic asthma
- severe type 2 asthma
- SevereAcuteRespiratorySyndromeCoronavirus2[SupplementaryConcept]
- severeallergicreactions
- severity
- sIgG
- Single nucleotide polymorphisms (SNPs)
- sinus
- sinusitis
- Skin
- skin allergy
- Skin barrier
- skin diseases
- skin test
- Skincare
- sleep pattern
- smell
- SoMe
- Spirometry
- sport
- Sports
- sputuminduction
- Stallergenes Greer
- standardization
- StandUp Talks
- Stevens-Johnson syndrome (SJS)
- Stratification
- subcutaneous immunotherapy
- Sublingual
- sublingual immunotherapy
- sulforaphane
- Sulfur mustard Stem cells
- survey
- Symptom scale
- Symptom score
- synbiotics
- system biology
- systematic mastocytosis
- Systemic mastocytosis (SM)
- T cells
- T cells
- t2 diseases
- Takeda
- TAKHZYRO
- Tcells
- teenager
- tele-health
- teleHealth
- telemedicine
- Terriers
- Tezepelumab
- Th2 cell
- Th2 sensitization
- therapies
- Thermo Fisher Scientific
- threshold dose
- Thunderstorm asthma
- TLR
- TMPRSS2
- tolerance
- Trained immunity
- trainedimmunity
- Transcriptome
- Transcriptomics
- transition
- Transition process
- translationalresearch
- transmissionofdisease
- treatment
- tree nut allergy
- Tree-nut allergy
- Trichinella spiralis
- Tryptase
- TSLP: a key epithelial cytokine at the top of the asthma inflammatory cascade
- type 2 inflammation
- UCARE
- unmet needs
- Urban green spaces
- Urban particulate matter
- Urticaria
- urticaria in children
- urticarial vasculitis
- Vaccination
- vaccine
- Vaccines
- Vaping
- Venom and insect allergy
- venom immunotherapy
- Viral reactivation
- Virtual care
- Virus
- WAO
- wheal
- wheezing child
- white paper
- World Health Organization (WHO)
- WS 2023 Davos
- Xlinkedagammaglobulinemia
- yellow fever
- young adult
- young adults
- young children
Author
- Aberer, W.
- Achten, R.
- Adamiec, A.
- Adcock, I.
- Agache, I.
- Aggelides, X.
- Akdis, C.A.
- Akdis, M.
- Akin, C.
- Allegri, P.
- Altrichter, S.
- Alvarez-Cuesta, E.
- Alvarez-Perea, A.
- Alvaro-Lozano, M.
- Alviani, C.
- Ambrożej, D.
- Angier, E.
- Annesi-Maesano, I.
- Antolin-Amerigo, D.
- Antunes, C.
- Apoil, P.
- Arasi, S.
- Arcolaci, A.
- Ardern-Jones, M.R.
- Arkhipova, S.
- Arnold, A.
- Arrais, M.
- Asero, R.
- Atanaskovic-Markovic, M.
- Ayane, A.
- Aygören-Pürsün, E.
- Bacharier, L.
- Bachert, C.
- Baerenfaller, K.
- Bansal, P.
- Barbaud, A.
- Barber, D.
- Bartel, S.
- Bartra, J.
- Baumann, R.
- Bavbek, S.
- Bazan-Socha, S.
- Beausoleil, J.
- Beck, E.
- Beck, L.
- Bégin, P.
- Beken, B.
- Benito Villalvilla, C.
- Bergmann, C.
- Bernard, A.
- Bernstein, D.
- Bernstein, J.
- Besednjak-Kocijancic, L.
- Betschel, S.
- Beyer, K.
- Bianchini, R.
- Biedermann, T.
- Birrell, F.
- Bisyuk, Y.
- Blanca-Lopez, N.
- Blasi, F.
- Blümchen, K.
- Boccabella, C.
- Boguniewciz, M.
- Bohle, B.
- Böhm, I.
- Bonini, M.
- Borres, M.
- Bosco, A.
- Bosnic-Anticevich, S.
- Bossios, A.
- Bousquet, J.
- Boyce, J.
- Boyle, R.
- Bozek, A.
- Bozkurt, B.
- Braido, F.
- Branicka, O.
- Braun, A.
- Braunstahl, G.
- Bredenoord, A.
- Brignole-Baudouin, F.
- Brockow, K.
- Brough, H.A.
- Brucker, H.
- Brusselle, G.
- Burks, W.
- Busse, W.
- Caballero, M.
- Cabanillas, B.
- Cabrera, M.
- Calado, R.
- Calder, V.
- Calderon, M.
- Calvão, J.
- Camargo Lopes de Oliveira, L.
- Campbell, D.
- Canonica, G.W.
- Cardona, V.
- Carnés, J.
- Carter, M.
- Casale, T.
- Castells, M.
- Castillejo, G.
- Caubet, J.-C.
- Cavaleiro Rufo, J.
- Chaker, A.
- Chan, E.
- Chandra, A.
- Chawes, B.
- Chehade, M.
- Chivato, T.
- Cho, Y.
- Chung, K.
- Cianferoni, A.
- Cimbollek, S.
- Clark, A.
- Clark, E.
- Cogo, A.
- Cojanu, C.
- Comberiati, P.
- Constantinides, M.
- Corbett, M.
- Cornejo-Garcia, J.A.
- Corren, J.
- Corrigan, C.
- Coutinho, C.
- Couto, M.
- Craig, T.
- Cullinan, P.
- Cunha, I.
- Custovic, A.
- D'Amato, G.
- Davidescu, L.
- Dávila, I.
- de Blay, F.
- De Craemer, J.
- de Jong, N.
- de las Vecillas, L.
- de Silva, D.
- de Swart, R.
- de Waard-van der Spek, F.
- del Giacco, S.
- Delgado, L.
- Demoly, P.
- Descamps, V.
- Deschildre, A.
- Deshpande, D.
- di Bona, D.
- Diamant, Z.
- Diwakar, L.
- Doğru, M.
- Domínguez Andrés, J.
- Doña, I.
- Dörr, T.
- Dramburg, S.
- Drijver-Messelink, M.T.
- du Toit, G.
- Dunn Galvin, A.
- DunnGalvin, A.
- Durham, S.
- Eberlein, B.
- Ebisawa, M.
- Ebo, D.G.
- Eggel, A.
- Eguiluz-Gracia, I.
- Eguiluz, I.
- Eigenmann, P.
- Eiwegger, T.
- Elenius, V.
- Eljaszewicz, A.
- Emeryk, A.
- Emson, C.
- Eyerich, K.
- Fakhimahmadi, A.
- Farkas, H.
- Fauquert, J.
- Favaro, A.
- Feketea, G.
- Feleszko, W.
- Fernández Santamaría, R.
- Fernández-Rivas, M.
- Ferrando anaut, P.
- Fieten, K.B.
- Figueras Alsius, M.
- Fiocchi, A.
- Flokstra – de Blok, B.M.J.
- Florsheim, E.
- Fokkens, W.
- Fonseca, J.
- Forastiere, F.
- Freemantle, N.
- Fritzsching, B.
- Fu, W.
- Gainsborough, F.
- Galvan Blasco, P.
- Gamez, C.
- Gappa, M.
- Garvey, L.H.
- Gaudenzio, N.
- Gelincik, A.
- Geng, B.
- Gennery, A.
- Genuneit, J.
- Gern, J.
- Gerth van Wijk, R.
- Gervasoni, M.E.
- Gevaert, P.
- Gherasim, A.
- Giménez-Arnau, A.
- Giovannini, M.
- Gobert, D.
- Golding, M.
- Gomes, E.R.
- Gomes, J.
- Gonçalo, M.
- Goncalo, M.
- González Díaz, S.
- González germán, M.
- Goodman, R.
- Goossens, A.
- Gore, C.
- Grattan, C.
- Greenhawt, M.
- Grigg, J.
- Grimshaw, K.
- Gunawardana, N.
- Gupta, R.
- Gutermuth, J.
- Guttman-Yassky, E.
- Guttman, E.
- Halken, S.
- Hamilton, J.
- Hartmann, K.
- Heffler, E.
- Heine, R.
- Heldner, A.
- Hellings P.
- Hermuth-Kleinschmidt, K.
- Hilger, C.
- Hirahara, K.
- Hoffmann-Sommergruber, K.
- Holgate, S.
- Holmdahl, I.
- Holmes, S.
- Howarth, P.
- Huang, Y.
- Humbert, M.
- In't Veen, H.
- Izquierdo, E.
- Izuhara, K.
- Jackson, D.
- Jacobsen, L.
- Jakob, T.
- Janda, J.
- Jeebhay, M.
- Jeimy, S.
- Jensen-Jarolim, E.
- Jesenak, M.
- Jiménez-Saiz, R.
- Johnston, S.
- Jones, A.
- Juskiene, I.
- Jutel, M.
- K Chu, D.
- Kang, M.
- Kappen, J.
- Kase Tanno, L.
- Kelleher, M.
- Kessel, A.
- Khaitov, M.
- Khaleva, E.
- Kheradmand, F.
- Kiani-alikhan, S.
- Kılıç, A.
- Kleine-Tebbe, J.
- Kleuskens, M.
- Klimek, L.
- Knibb, R.
- Knol, E.
- Kocatürk, E.
- Köhler, V.
- Korath, A.D.J.
- Korn, S.
- Kortekaas Krohn, I.
- Kosowska, A.
- Kothalawala, D.
- Kozlik, P.
- Kucharczyk, A.
- Kuna, P.
- Kündig, T.
- Kupczyk, M.
- Kuziemski, K.
- Lack, G.
- Lang, D.
- Larché, M.
- Larenas-linnemann, D.
- Lau, S.
- Lauerma, A.
- Lee, Y.
- Leonardi, A.
- Levy, D.
- Liu, A.
- Lopata, A.
- Mack, D.
- Madrigal-Burgaleta, R.
- Magerl, M.
- Mahler, V.
- Mäkelä, M.
- Maleki, S.
- Malinovschi, A.
- Malmberg, P.L.
- Mantovani, A.
- Marcoux, D.
- Marrs, T.
- Marsella, R.
- Martins, C.
- Maspero, J.
- Mastalerz, L.
- Mathioudakis, A.
- Matricardi, P.
- Matucci, A.
- Maurer, M.
- Mayerhofer, H.
- Mayorga, C.
- McSorley, H.
- Melén, E.
- Menzies-Gow, A.
- Meyer, R.
- Michel, M.
- Mikkelsen, A.
- Mockenhaupt, M.
- Moloudizargari, M.
- Montimer, K.
- Mori, F.
- Mortz, C.G.
- Mösges, R.
- Moya, B.
- Mueller, R.S.
- Mukherjee, M.
- Mullol, J.
- Muraro, A.
- Myszkowska, D.
- Nadeau, K.C.
- Nasser, S.
- Novak, N.
- Nutten, S.
- Nwaru, B.
- O'B Hourihane, J.
- O’Mahony, L.
- Ogese, M.
- Ogg, G.
- Ogneva, D.
- Ollert, M.
- Ong, P.Y.
- Pagani, M.
- Pali-Schöll, I.
- Paller, A.
- Palomares, O.
- Paoletti, G.
- Papadopoulos, N.
- Paplinska-Goryca, M.
- Park, H.
- Pascal, M.
- Pasmans, S.
- Pavlova, K.
- Pavord, I.
- Peden, D.
- Pérez de Llano, L.
- Perkin, M.
- Permaul, P.
- Peters, A.
- Pfaar, O.
- Pietikäinen, S.
- Pite, H.
- Pitsios, C.
- Poli, A.
- Popescu, F.
- Porsbjerg, C.
- Portelli, M.
- Price, O.J.
- Prunicki, M.
- Qazi, K.
- Quirce, S.
- Rabe, K.F.
- Radzikowska, U.
- Recke, A.
- Reese, I.
- Reginald, K.
- Renz, H.
- Reynolds, N.
- Ricci, C.
- Roberts, G.
- Roberts, G.
- Rodrigo-Muñoz, J.
- Rodrigues-Cernadas, J.
- Rodríguez Del Río, P.
- Rondon, C.
- Rossi, A.
- Rostaher, A.
- Roth-Walter, F.
- Rothenberg, M.
- Rouger, M.
- Rovati, G.E.
- Rubin, E.
- Rudenko, M.
- Rustemeyer, T.
- Ryan, D.
- Sabato, V.
- Sabouraud, D.
- Sadeghi, S.
- Sala Cunill, A.
- Salapatek, A.
- Sampson, H.
- Sandoval-Ruballos, M.
- Santos, A.
- Sastre, J.
- Satyaraj, E.
- Savic, S.
- Scadding, G.
- Scheib, N.
- Scherrer, K.
- Schmid, B.
- Schuijs, M.
- Schwarze, J.
- Sediva, A.
- Sekerel, B.
- Semernik, O.
- Serrano, C.
- Sevciovic Grumach, A.
- Shamji, M.H.
- Siebenhaar, F.
- Siegfried, E.
- Skypala, I.J.
- Smolinska, S.
- Sokolowska, M.
- Solinski, M.
- Song, K.
- Sorensen, K.
- Spanevello, A.
- Spergel, J.
- Spolak-Bobryk, N.
- Spriggs, K.
- Stevens, W.
- Stobiecki, M.
- Stratton. R.
- Straumann, A.
- Sturm, G.
- Sublett, J.
- Suojalehto, H.
- Suprun, M.
- Swanson, W.S.
- Szajewska, H.
- Szefler, S.
- Szymanski, L.
- Tan, B.
- Tanno, L.
- Tham, E.
- Thibaudon, M.
- Thien, F.
- Thirumala Krishna, M.
- Togias, A.
- Tomazic, P.
- Torrado español, I.
- Torres, M.J.
- Torun, E.
- Traidl-Hoffmann, C.
- Tramper-Stranders, G.
- Trautmann, A.
- Troy, N.
- Tsabouri, S.
- Tsilochristou, O.
- Ueki, S.
- Untersmayr, E.
- Vaia, E.
- Van Bilsen, J.
- Van Cuilenborg, V.
- van den Berge, M.
- Van Dijk, Y.
- van Neerven, R.
- van Ree, R.
- Van Schijndel, H.
- Van Weissenbruch, R.
- Vandenplas, Y.
- Vassilopoulou, E.
- Vazquez-Ortiz, M.
- Vega Castro, A.
- Venter, C.
- Verhasselt, V.
- Villaseñor solis, A.
- Vitte, J.
- Vlieg- Boerstra, B.
- Vogelberg, C.
- von Mutius, E.
- Vultaggio, A.
- Walsted, E.S.
- Walter, J.
- Wang, J.
- Wardzynska, A.
- Warner, A.
- Wechsler, M.
- Weidner, J.
- Weinberger, B.
- Werfel, T.
- Wiehn, E.
- Williams, S.
- Wong, C.
- Worm, M.
- Xepapadaki, V.
- Yuste-Montalvo, A.
- Zednik, K.
- Zhang, L.
- Zieglmayer, P.
- Zissler, U.M.
- Zuberbier, T.

Presentation 19/06/2020

Ligelizumab achieves high rate of complete response in patients with moderate to severe chronic spontaneous urticaria
- Bernstein, J.
Read about this Presentation
Presentation 19/06/2020

Long-term dupilumab treatment for 100 weeks reduces serum TARC and total IgE in patients with moderate-to-severe atopic dermatitis
- Beck, L.
Read about this Presentation
Presentation 19/06/2020

Genetic polymorphisms of CD14 and TLR-4 and utility of probiotic therapy in adults with atopic dermatitis
- Bisyuk, Y.
Read about this Presentation
Presentation 19/06/2020

Implementation of a novel DBS-based methodology to diagnose hereditary angioedema in subjects with recurrent abdominal pain of unclear etiology – the international EHA study
- Kuziemski, K.
Read about this Presentation
Presentation 19/06/2020

Precision medicine and biomarkers of atopic dermatitis
- Traidl-Hoffmann, C.
Read about this Presentation
Presentation 19/06/2020

The clinical clues and pitfalls in contact dermatitis
- Rustemeyer, T.
Read about this Presentation
Presentation 19/06/2020

Skin care from birth for allergy prevention: results today
- Brough, H.A.
Read about this Presentation
Presentation 19/06/2020

Using the “atopic dermatitis yardstick” in clinical practice
- Sublett, J.
Read about this Presentation
Presentation 19/06/2020

Precision medicine and biomarkers in chronic rhinosinusitis with nasal polyps
- Zhang, L.
Read about this Presentation
Presentation 19/06/2020

Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study
- Hartmann, K.
Read about this Presentation
Presentation 19/06/2020

Implementing biomarkers in immunophenotyping of atopic dermatitis
- Knol, E.
Read about this Presentation
Presentation 19/06/2020

Anti-inflammatory activities of IL-37b on atopic dermatitis via regulating AMPK-mTOR and intestinal metabolites-dependent autophagy
- Wong, C.
Read about this Presentation
Presentation 19/06/2020

Potential biomarkers for diagnosis and treatment for CSU
- Asero, R.
Read about this Presentation
Presentation 19/06/2020

Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project
- Kocatürk, E.
Read about this Presentation
Presentation 19/06/2020

Understanding parent preferences for paediatric allergy services
- Diwakar, L.
Read about this Presentation
Presentation 19/06/2020

Preparing a grant: Dos and Don’ts
- McSorley, H.
Read about this Presentation
Presentation 19/06/2020

The effect of tezepelumab in patients with allergic asthma: Results from the PATHWAY phase IIb study
- Corren, J.
Read about this Presentation
Presentation 19/06/2020

The therapeutic and preventive effect of sublingual immunotherapy in mite-sensitized children with atopic dermatitis: A randomized, open, parallel-group study
- Song, K.
Read about this Presentation
Presentation 19/06/2020

Fractional exhaled nitric oxide levels and eosinophil counts after cessation of tezepelumab: Results from the PATHWAY phase 2b study
- Pavord, I.
Read about this Presentation
Presentation 19/06/2020

Increased bathing during infancy is associated with impaired skin barrier function, increased atopic dermatitis and reduced skin prick sensitisation to peanut and egg
- Marrs, T.
Read about this Presentation
Presentation 19/06/2020

Seasonal variability of exacerbations in patients with severe, uncontrolled asthma and clinical benefits of tezepelumab: Results from the PATHWAY phase 2b study
- Corren, J.
Read about this Presentation
Presentation 19/06/2020

Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015
- Davidescu, L.
Read about this Presentation
Presentation 19/06/2020

Food diversity during the first year and risk of atopic eczema and food allergy up to 12 years of age
- Nwaru, B.
Read about this Presentation
Presentation 19/06/2020

Effects of tezepelumab on asthma exacerbations, type 2 biomarkers, lung function and asthma control in patients with severe, uncontrolled asthma with and without nasal polyps: PATHWAY phase IIb study
- Emson, C.
Read about this Presentation
Presentation 19/06/2020

Dupilumab associated with lower reports of respiratory infections in moderate-to-severe asthma – safety analysis from the LIBERTY ASTHMA QUEST study
- Geng, B.
Read about this Presentation
Presentation 19/06/2020

Development of a childhood asthma prediction model using machine learning approaches
- Kothalawala, D.
Read about this Presentation
Presentation 19/06/2020

Benralizumab efficacy for severe, eosinophilic asthma with a diagnosis of nasal polyposis: Results from the phase IIIb ANDHI trial
- Canonica, G.W.
Read about this Presentation
Presentation 19/06/2020

A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study
- Maspero, J.
Read about this Presentation
Presentation 19/06/2020

Covid 19 and air pollution: is there a relationship?
- D'Amato, G.
Read about this Presentation
Presentation 19/06/2020

E-cigarettes: mechanistic link to lung injury
- Kheradmand, F.
Read about this Presentation
Presentation 19/06/2020

Three-year follow-up of the 2016 Melbourne Epidemic Thunderstorm Asthma patients: Insight into symptoms, healthcare seeking, and medication compliance
- Thien, F.
Read about this Presentation
Presentation 19/06/2020

Urban green spaces – The exposure and allergenicity index
- Thibaudon, M.
Read about this Presentation
Presentation 19/06/2020

Dynamic and Behavior of plane tree pollen and its relationship with Pla a 1 aeroallergen concentration in Évora (Portugal)
- Antunes, C.
Read about this Presentation
Presentation 19/06/2020

Indoor air quality in primary schools is associated with atopic sensitization, airway inflammation and FEV1 reversibility in schoolchildren
- Cavaleiro Rufo, J.
Read about this Presentation
Presentation 19/06/2020

Alternaria-induced thunderstorm asthma: An unrecognised trigger
- Nasser, S.
Read about this Presentation
Presentation 19/06/2020

Can the birch pollen be more aggressive in the polluted environments?
- Myszkowska, D.
Read about this Presentation
Presentation 19/06/2020

Healthcare use and asthma control among overweight/obese urban children sensitized and exposed to classroom allergens
- Permaul, P.
Read about this Presentation
Presentation 19/06/2020

Air pollution-induced augmented allergenicity of Platanus hybrida pollen in urban environments
- Antunes, C.
Read about this Presentation
Presentation 19/06/2020

Early life wheeze – risk factors for asthma in school age
- Holmdahl, I.
Read about this Presentation
Presentation 19/06/2020

FeNO, forced oscillation, or spirometry? Lung function testing in wheezy pre-schoolers and the prediction of asthma, a systematic review
- Adamiec, A.
Read about this Presentation
Presentation 19/06/2020

Does probiotic microorganism lactobacillus reuteri prevents allergic rhinitis and rhinoconjunctivitis development in children
- Besednjak-Kocijancic, L.
Read about this Presentation
Presentation 19/06/2020

Tezepelumab (anti-TSLP) in asthma
- Corren, J.
Read about this Presentation
Presentation 19/06/2020

Impact of climate change on asthma exacerbations
- González Díaz, S.
Read about this Presentation
Presentation 19/06/2020

Impact of climate change on the immune system
- Peden, D.
Read about this Presentation
Presentation 19/06/2020

Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study
- Portelli, M.
Read about this Presentation
Presentation 19/06/2020

Novel therapeutic approaches targeting endotypes of severe airway disease
- Gevaert, P.
Read about this Presentation
Presentation 19/06/2020

Interferon therapy in airway disease: prophylaxis is the new approach in exacerbation prevention?
- Johnston, S.
Read about this Presentation
Presentation 19/06/2020

Ligelizumab (anti-IgE) in chronic spontaneous urticaria
- Maurer, M.
Read about this Presentation
Presentation 19/06/2020

B cells in in chronic rhinosinusitis: friend or foe
- Peters, A.
Read about this Presentation
Presentation 19/06/2020

Dupilumab (anti-IL4Ra) in CRSwNP
- Bachert, C.
Read about this Presentation
Presentation 19/06/2020

Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases
- Corren, J.
Read about this Presentation
Presentation 19/06/2020

Exercise: induced asthma and rhinitis
- Pite, H.
Read about this Presentation
Presentation 19/06/2020

Exercise-induced urticaria and anaphylaxis
- del Giacco, S.
Read about this Presentation
Presentation 19/06/2020

The α2β1 integrin, a collagen-binding receptor, may be involved in pathology of airway remodelling in asthma
- Bazan-Socha, S.
Read about this Presentation
Presentation 19/06/2020

Potential role of mir-185-5P as feedback mechanism for controlling airway remodeling and smooth muscle contraction
- Rodrigo-Muñoz, J.
Read about this Presentation
Presentation 19/06/2020

Skin mycobiome sequencing reveals a high fungal diversity in patients with severe atopic dermatitis
- Schmid, B.
Read about this Presentation
Presentation 19/06/2020

Age-related changes in innate immune response to in vitro rhinovirus infection in asthma patients
- Wardzynska, A.
Read about this Presentation
Presentation 19/06/2020

NEK7-NLRP3 binding is essential in the assembly of NLRP3 inflammasome in the pathogenesis of house dust mite-induced asthma
- Lee, Y.
Read about this Presentation
Presentation 19/06/2020

Hypereosinophilic syndromes and autoimmunity
- Matucci, A.
Read about this Presentation
Presentation 19/06/2020

Immune response to Corona virus infection
- Akdis, C.A.
Read about this Presentation
Presentation 19/06/2020

Hologenome and obesity
- O’Mahony, L.
Read about this Presentation
Presentation 19/06/2020

Real-world clinical outcomes for patients in the UK with severe, atopic eosinophilic asthma treated with benralizumab
- Jackson, D.
Read about this Presentation
Presentation 19/06/2020

Lung function testing
- Chivato, T.
Read about this Presentation
Presentation 19/06/2020

Novel pharamacological targets
- Eguiluz, I.
Read about this Presentation
Presentation 19/06/2020

Stratification of asthma phenotypes by airway proteomic signatures: A system biology approach
- Adcock, I.
Read about this Presentation
Presentation 19/06/2020

Dupilumab reduces severe exacerbations in patients with uncontrolled, moderate-to-severe allergic (atopic) asthma regardless of presence of perennial aeroallergen-specific IgE: LIBERTY ASTHMA QUEST
- Corren, J.
Read about this Presentation
Presentation 19/06/2020

Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life
- Van Bilsen, J.
Read about this Presentation
Presentation 19/06/2020

Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis
- Jones, A.
Read about this Presentation
Presentation 19/06/2020

Protection against lower respiratory infections in a high-risk infant cohort with a microbial-derived immunomodulator
- Troy, N.
Read about this Presentation
Presentation 19/06/2020

Genome-wide association studies on individuals from han chinese background reveal novel genes as potential risk factors for allergic rhinitis
- Reginald, K.
Read about this Presentation
Presentation 19/06/2020

Mechanisms of airway remodeling unique to eosinophilic asthma: Insights from differential gene co-expression analysis
- Kozlik, P.
Read about this Presentation
Presentation 19/06/2020

Quality of life in mastocytosis scale (QLMS) – the construction of the disease-specific questionnaire
- Spolak-Bobryk, N.
Read about this Presentation
Presentation 19/06/2020

Biologicals in allergy and asthma: A deep learning approach to optimized patient management
- Agache, I.
Read about this Presentation
Presentation 19/06/2020

Cow’s milk allergy can be monitored through the degree of competition between specific IgE and IgG
- Apoil, P.
Read about this Presentation
Presentation 19/06/2020

Impact of food allergy on household expenditures among Manitoba families
- Golding, M.
Read about this Presentation

EAACI 2020

What are you looking for?

Ligelizumab achieves high rate of complete response in patients with moderate to severe chronic spontaneous urticaria

Long-term dupilumab treatment for 100 weeks reduces serum TARC and total IgE in patients with moderate-to-severe atopic dermatitis

Genetic polymorphisms of CD14 and TLR-4 and utility of probiotic therapy in adults with atopic dermatitis

Implementation of a novel DBS-based methodology to diagnose hereditary angioedema in subjects with recurrent abdominal pain of unclear etiology – the international EHA study

Precision medicine and biomarkers of atopic dermatitis

The clinical clues and pitfalls in contact dermatitis

Skin care from birth for allergy prevention: results today

Using the “atopic dermatitis yardstick” in clinical practice

Precision medicine and biomarkers in chronic rhinosinusitis with nasal polyps

Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study

Implementing biomarkers in immunophenotyping of atopic dermatitis

Anti-inflammatory activities of IL-37b on atopic dermatitis via regulating AMPK-mTOR and intestinal metabolites-dependent autophagy

Potential biomarkers for diagnosis and treatment for CSU

Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project

Understanding parent preferences for paediatric allergy services

Preparing a grant: Dos and Don’ts

The effect of tezepelumab in patients with allergic asthma: Results from the PATHWAY phase IIb study

The therapeutic and preventive effect of sublingual immunotherapy in mite-sensitized children with atopic dermatitis: A randomized, open, parallel-group study

Fractional exhaled nitric oxide levels and eosinophil counts after cessation of tezepelumab: Results from the PATHWAY phase 2b study

Increased bathing during infancy is associated with impaired skin barrier function, increased atopic dermatitis and reduced skin prick sensitisation to peanut and egg

Seasonal variability of exacerbations in patients with severe, uncontrolled asthma and clinical benefits of tezepelumab: Results from the PATHWAY phase 2b study

Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015

Food diversity during the first year and risk of atopic eczema and food allergy up to 12 years of age

Effects of tezepelumab on asthma exacerbations, type 2 biomarkers, lung function and asthma control in patients with severe, uncontrolled asthma with and without nasal polyps: PATHWAY phase IIb study

Dupilumab associated with lower reports of respiratory infections in moderate-to-severe asthma – safety analysis from the LIBERTY ASTHMA QUEST study

Development of a childhood asthma prediction model using machine learning approaches

Benralizumab efficacy for severe, eosinophilic asthma with a diagnosis of nasal polyposis: Results from the phase IIIb ANDHI trial

A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study

Covid 19 and air pollution: is there a relationship?

E-cigarettes: mechanistic link to lung injury

Three-year follow-up of the 2016 Melbourne Epidemic Thunderstorm Asthma patients: Insight into symptoms, healthcare seeking, and medication compliance

Urban green spaces – The exposure and allergenicity index

Dynamic and Behavior of plane tree pollen and its relationship with Pla a 1 aeroallergen concentration in Évora (Portugal)

Indoor air quality in primary schools is associated with atopic sensitization, airway inflammation and FEV1 reversibility in schoolchildren

Alternaria-induced thunderstorm asthma: An unrecognised trigger

Can the birch pollen be more aggressive in the polluted environments?

Healthcare use and asthma control among overweight/obese urban children sensitized and exposed to classroom allergens

Air pollution-induced augmented allergenicity of Platanus hybrida pollen in urban environments

Early life wheeze – risk factors for asthma in school age

FeNO, forced oscillation, or spirometry? Lung function testing in wheezy pre-schoolers and the prediction of asthma, a systematic review

Does probiotic microorganism lactobacillus reuteri prevents allergic rhinitis and rhinoconjunctivitis development in children

Tezepelumab (anti-TSLP) in asthma

Impact of climate change on asthma exacerbations

Impact of climate change on the immune system

Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study

Novel therapeutic approaches targeting endotypes of severe airway disease

Interferon therapy in airway disease: prophylaxis is the new approach in exacerbation prevention?

Ligelizumab (anti-IgE) in chronic spontaneous urticaria

B cells in in chronic rhinosinusitis: friend or foe

Dupilumab (anti-IL4Ra) in CRSwNP

Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases

Exercise: induced asthma and rhinitis

Exercise-induced urticaria and anaphylaxis

The α2β1 integrin, a collagen-binding receptor, may be involved in pathology of airway remodelling in asthma

Potential role of mir-185-5P as feedback mechanism for controlling airway remodeling and smooth muscle contraction

Skin mycobiome sequencing reveals a high fungal diversity in patients with severe atopic dermatitis

Age-related changes in innate immune response to in vitro rhinovirus infection in asthma patients

NEK7-NLRP3 binding is essential in the assembly of NLRP3 inflammasome in the pathogenesis of house dust mite-induced asthma

Hypereosinophilic syndromes and autoimmunity

Immune response to Corona virus infection

Hologenome and obesity

Real-world clinical outcomes for patients in the UK with severe, atopic eosinophilic asthma treated with benralizumab

Lung function testing

Novel pharamacological targets

Stratification of asthma phenotypes by airway proteomic signatures: A system biology approach

Dupilumab reduces severe exacerbations in patients with uncontrolled, moderate-to-severe allergic (atopic) asthma regardless of presence of perennial aeroallergen-specific IgE: LIBERTY ASTHMA QUEST

Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life

Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis

Protection against lower respiratory infections in a high-risk infant cohort with a microbial-derived immunomodulator

Genome-wide association studies on individuals from han chinese background reveal novel genes as potential risk factors for allergic rhinitis

Mechanisms of airway remodeling unique to eosinophilic asthma: Insights from differential gene co-expression analysis

Quality of life in mastocytosis scale (QLMS) – the construction of the disease-specific questionnaire

Biologicals in allergy and asthma: A deep learning approach to optimized patient management

Cow’s milk allergy can be monitored through the degree of competition between specific IgE and IgG

Impact of food allergy on household expenditures among Manitoba families